Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
about
P1343
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitisStimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer typesCombination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunitiesTherapeutic cancer vaccines: past, present, and futureDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsIntestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarizationTolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine SplenocytesPlasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in miceToll-like receptor-mediated activation of neutrophils by influenza A virusCell Type-Specific Recognition of Human Metapneumoviruses (HMPVs) by Retinoic Acid-Inducible Gene I (RIG-I) and TLR7 and Viral Interference of RIG-I Ligand Recognition by HMPV-B1 PhosphoproteinAdjuvants for peptide-based cancer vaccinesDifferent cross-presentation pathways in steady-state and inflammatory dendritic cellsSaponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formationCanonical and noncanonical Wnt proteins program dendritic cell responses for toleranceNonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulumPD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsCurrent status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.Tumor Therapy Applying Membrane-bound Form of Cytokines.Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytesAttenuation of vaccinia virus by the expression of human Flt3 ligandThe nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs.Ontogenic, Phenotypic, and Functional Characterization of XCR1(+) Dendritic Cells Leads to a Consistent Classification of Intestinal Dendritic Cells Based on the Expression of XCR1 and SIRPαLuminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccineCX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells.Role of GM-CSF signaling in cell-based tumor immunization.Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutininPlasmacytoid dendritic cells: recent progress and open questionsSuppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in miceIn vivo requirement for Atg5 in antigen presentation by dendritic cells.RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.Robust expansion of dendritic cells in vivo by hydrodynamic FLT3L-FC gene transfer.Generation of inducible immortalized dendritic cells with proper immune function in vitro and in vivo.Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFα release via RAGE- and TLR9-responsive plasmacytoid dendritic cells.
P2860
Q24531314-F752BD5C-2248-47C8-9D9E-089B2F9FDC6AQ24631662-C72C7F88-4095-40AF-8084-57E050339DFAQ26745894-AC522261-CB37-4548-8784-C68A6E2C7E44Q26851710-4EED6EBD-A9BF-4643-B03E-8FCCBF222E26Q26863283-48FF5565-C8A6-40E8-ACA2-7D8BD6A89486Q27012618-18FB0901-5365-4D1E-9A27-858D92F366AEQ27301176-9AA71C52-81AE-428A-9604-D3452AD2608DQ27302768-FD7DB86C-C128-452B-BB2E-99C6AFE594F0Q27340476-BB91ACAB-E790-40FD-ABEA-A6128E9EAD70Q27486669-CF51B864-1FAA-46B4-B0A4-76946848563BQ27491027-17B5C950-93BE-4743-8ECB-0A518DEDFE90Q28072236-B44D23E4-C544-4C0B-88A1-D1A92655DD69Q28115137-D8F311FD-6B5E-4250-8C89-BD3C9806F417Q28393754-49969CD9-F995-46D4-83B2-9FA61D1278FDQ28510103-19AA43B8-5739-460B-A7DC-1E7BF7331286Q28941251-D4747605-4C62-4804-82E1-A8FA4121BB6AQ29619686-46012ABF-8C08-4D7B-AD91-4939D2BAA189Q30412300-1468A6A3-5819-41DE-ADDB-EB0186F3F8EFQ30894063-8C750D9A-69E8-47A8-8308-90DE1A857452Q33384384-17642CCF-8EB1-41CC-852B-D1572CEFD308Q33631960-B45473CD-E23F-4161-8657-8FDE08CE0E2DQ33787115-B6630428-51CA-4240-A045-EF7959635B5FQ33907236-95513904-D4DD-44AD-BB0D-35972D269815Q33936854-A9076A6E-2814-47C0-BCA9-EB841E68BE25Q33958439-8F2E0C39-0F69-4C96-B3C9-9966EF2FAA63Q33970555-C13B9F25-F9FD-4CED-BDD4-40C610876E7AQ33980867-D95ADF6D-2A69-4D88-8E0D-7621F3062B66Q34015676-D1E7CF77-4B6C-4CA7-8D88-B45CB158F58FQ34028154-3410B61E-782C-45B6-BE44-2EADB701BBDEQ34059854-766FEBDA-FB78-48D7-894A-49B524D228C9Q34093092-16A025A9-9E24-4EC0-9EC7-028452542605Q34147010-895A2936-DBE3-4262-BC1A-E6EBF1DA7B20Q34147894-0036AD8D-D8C1-4B4B-A144-2AF4F86AD909Q34162925-D1CEF442-7DFD-4D77-A12F-1DB18E5BD22BQ34228443-937B75BF-2FC4-4A60-A0B2-8DAC562B572AQ34376166-A847C90F-95E2-4FA9-8FAC-BFE75468724EQ34486464-EA7DCE04-4025-4A01-971C-5E3215D993ECQ34617169-6C017E46-89FD-4042-A931-170AA6031D6BQ34693337-0C6EB4C3-4316-416C-84B8-81A62912ED3BQ34951563-D7412A6B-3471-4ADB-BF8F-0030CA14C1CF
P2860
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@en
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@nl
type
label
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@en
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@nl
prefLabel
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@en
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@nl
P2093
P1433
P1476
Differences in dendritic cells ...... ulating factor or Flt3-ligand.
@en
P2093
P304
P407
P4510
P577
2000-06-01T00:00:00Z